Drug intelligence / Profile preview

declinol

Development stage
Preclinical
Lead developer
Declinol
Modality
Small Molecules
Administration
Oral
01

Overview

Declinol is an **over-the-counter dietary supplement** formulated to support the reduction of alcohol cravings and consumption. Its composition is based on traditional herbal and botanical compounds, including **kudzu root extract (containing daidzin)**, **gentian (bitter herb)**, **tangerine peel**, **radix bupleuri**, **rehmannia**, **licorice root**, and a **blend of B vitamins and other micronutrients**. The supplement leverages the mechanism of **daidzin from kudzu**, a **selective inhibitor of aldehyde dehydrogenase 2 (ALDH-2)**, which leads to the accumulation of acetaldehyde during alcohol metabolism, producing aversive effects that can reduce alcohol intake. Declinol also incorporates bitters that stimulate gut TAS2R receptors, thought to synergistically reduce alcohol cravings, while additional ingredients such as radix bupleuri may have neuroprotective effects, modulating neurotransmitters (endorphins, dopamine, epinephrine). The formulation uses **encapsulation technology** for enhanced bioavailability of active phytonutrients.

Brand names
Declinol
Other names
declinol
02

Targets

ALDH2 (Mitochondrial Aldehyde Dehydrogenase)TAS2R (Taste receptor type 2 family)

Beyond the preview

Go deeper on declinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on declinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call